Advertisement

Topics

Idorsia gets share of ponesimod and cadazolid revenues from Actelion

15:40 EDT 20 Jun 2017 | Elsevier Business Intelligence

Idorsia Pharmaceuticals Ltd. entered a revenue sharing agreement with Actelion Pharmaceuticals Ltd., from which it spun off e...

Original Article: Idorsia gets share of ponesimod and cadazolid revenues from Actelion

NEXT ARTICLE

More From BioPortfolio on "Idorsia gets share of ponesimod and cadazolid revenues from Actelion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...